MeSH Browser

MeSH Heading: Medigoxin
Tree Number(s): D04.210.500.155.580.130.500.436.500; D04.210.500.155.580.130.688.500; D09.408.180.261.436.500
Unique ID: D008520
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D008520
Scope Note: A semisynthetic digitalis glycoside with the general properties of DIGOXIN but more rapid onset of action. Its cardiotonic action is prolonged by its demethylation to DIGOXIN in the liver. It has been used in the treatment of congestive heart failure (HEART FAILURE).
Entry Term(s): 4'''-O-Methyldigoxin; Bemecor; Lanirapid; Lanitop; Medixin; Methyldigoxin; Metildigoxin; beta-Methyldigoxin
Pharm Action: Anti-Arrhythmia Agents
Cardiotonic Agents
Enzyme Inhibitors
Registry Numbers: I7GG1YUC5V; 0
Related Numbers: 30685-43-9
CAS Type 1 Name: Card-20(22)-enolide, 3-((O-2,6-dideoxy-4-O-methyl-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-
Previous Indexing: Digoxin (1966-1978)
Public MeSH Note: 91; was see under DIGOXIN 1979-90
History Note: 91(79); was see under DIGOXIN 1979-90
Date Established: 1991/01/01
Date of Entry: 1978/03/20
Revision Date: 2017/05/24

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Concept UI: M0013272
Registry Numbers: I7GG1YUC5V
Related Numbers: 30685-43-9
Scope Note: A semisynthetic digitalis glycoside with the general properties of DIGOXIN but more rapid onset of action. Its cardiotonic action is prolonged by its demethylation to DIGOXIN in the liver. It has been used in the treatment of congestive heart failure (HEART FAILURE).
Terms: Medigoxin Preferred Term
Term UI T025370
Date01/01/1999
LexicalTag NON
ThesaurusID; beta-Methyldigoxin
Term UI T025368
Date03/20/1978
LexicalTag NON
ThesaurusID UNK (19XX); Metildigoxin
Term UI T025371
Date03/20/1978
LexicalTag NON
ThesaurusID; 4'''-O-Methyldigoxin
Term UI T025372
Date03/20/1991
LexicalTag NON
ThesaurusID

Medigoxin MeSH Descriptor Data 2024